Cite
Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer.
MLA
Nunes, Sofia C., et al. “Cysteine Boosters the Evolutionary Adaptation to CoCl2 Mimicked Hypoxia Conditions, Favouring Carboplatin Resistance in Ovarian Cancer.” BMC Evolutionary Biology, vol. 18, no. 1, June 2018, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12862-018-1214-1.
APA
Nunes, S. C., Lopes-Coelho, F., Gouveia-Fernandes, S., Ramos, C., Pereira, S. A., & Serpa, J. (2018). Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer. BMC Evolutionary Biology, 18(1), N.PAG. https://doi.org/10.1186/s12862-018-1214-1
Chicago
Nunes, Sofia C., Filipa Lopes-Coelho, Sofia Gouveia-Fernandes, Cristiano Ramos, Sofia A. Pereira, and Jacinta Serpa. 2018. “Cysteine Boosters the Evolutionary Adaptation to CoCl2 Mimicked Hypoxia Conditions, Favouring Carboplatin Resistance in Ovarian Cancer.” BMC Evolutionary Biology 18 (1): N.PAG. doi:10.1186/s12862-018-1214-1.